Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Malabeja, A"'
Autor:
Eric Lyimo, Cyrielle Fougeroux, Anangisye Malabeja, Joyce Mbwana, Paul M. Hayuma, Edwin Liheluka, Louise Turner, Samwel Gesase, Thomas Lavstsen, John P. A. Lusingu, Daniel T. R. Minja, Christian W. Wang
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it
Externí odkaz:
https://doaj.org/article/eff79c4517d7451ca0c04a6980f0c34b
Autor:
Tinto, Halidou, Otieno, Walter, Gesase, Samwel, Sorgho, Hermann, Otieno, Lucas, Liheluka, Edwin, Valéa, Innocent, Sing'oei, Valentine, Malabeja, Anangisye, Valia, Daniel, Wangwe, Anne, Gvozdenovic, Emilia, Guerra Mendoza, Yolanda, Jongert, Erik, Lievens, Marc *, Roman, François, Schuerman, Lode, Lusingu, John
Publikováno v:
In The Lancet Infectious Diseases August 2019 19(8):821-832
Autor:
Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach, Marc Lievens, Opokua Ofori-Anyinam, Jean-Yves Pirçon, Jens-Ulrich Stegmann, Pascale Vandoolaeghe, Lucas Otieno, Walter Otieno, Seth Owusu-Agyei, Jahit Sacarlal, Nahya Salim Masoud, Hermann Sorgho, Marcel Tanner, Halidou Tinto, Innocent Valea, Ali Takadir Mtoro, Patricia Njuguna, Martina Oneko, Godfrey Allan Otieno, Kephas Otieno, Samwel Gesase, Mary J Hamel, Irving Hoffman, Seyram Kaali, Portia Kamthunzi, Peter Kremsner, Miguel Lanaspa, Bertrand Lell, John Lusingu, Anangisye Malabeja, Pedro Aide, Pauline Akoo, Daniel Ansong, Kwaku Poku Asante, James A Berkley, Samuel Adjei, Tsiri Agbenyega, Selidji Todagbe Agnandji, Lode Schuerman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2386-2398 (2019)
A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537
Externí odkaz:
https://doaj.org/article/32543b5d892e42548e7e71deabcf0cf8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lyimo, Eric, Fougeroux, Cyrielle, Malabeja, Anangisye, Mbwana, Joyce, Hayuma, Paul M., Liheluka, Edwin, Turner, Louise, Gesase, Samwel, Lavstsen, Thomas, Lusingu, John P. A., Minja, Daniel T. R., Wang, Christian W.
Additional file 2 The number of SARS-CoV-2 seropositive and negative infants in Kwamasimba and Mkokola villages based on age in months.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34db272420f38705ded07816b0933e63
Autor:
Olotu, Ally, Lusingu, John, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Msham, Salum, Lang, Trudie, Gould, Jayne, Dubois, Marie-Claude, Jongert, Erik, Vansadia, Preeti, Carter, Terrell, Njuguna, Patricia, Awuondo, Ken O, Malabeja, Anangisye, Abdul, Omar, Gesase, Samwel, Mturi, Neema, Drakeley, Chris J, Savarese, Barbara, Villafana, Tonya, Lapierre, Didier, Ballou, W Ripley, Cohen, Joe, Lemnge, Martha M, Peshu, Norbert, Marsh, Kevin, Riley, Eleanor M, von Seidlein, Lorenz, Bejon, Philip
Publikováno v:
In The Lancet Infectious Diseases 2011 11(2):102-109
Autor:
Denise Dekker, Omari A Msemo, John A. Crump, Samwel Gesase, Anangisye Malabeja, John Lusingu, Joyce Mbwana, Coline Mahende
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Salmonella enterica including Salmonella Typhi and nontyphoidal Salmonella (NTS) are the predominant cause of community-acquired bloodstream infections in sub-Saharan Africa (sSA). Multiple-drug resistance and emerging fluoroquinolone resi
Autor:
Irving F. Hoffman, Patricia Njuguna, Opokua Ofori-Anyinam, Pauline Akoo, Kwaku Poku Asante, Portia Kamthunzi, Walter Otieno, Miguel A. Lanaspa, Anangisye Malabeja, Godfrey Allan Otieno, Daniel Ansong, James A. Berkley, Halidou Tinto, John Lusingu, Mary J. Hamel, Selidji T Agnandji, Hermann Sorgho, Bertrand Lell, Nahya Salim Masoud, Seyram Kaali, Lode Schuerman, Innocent Valea, Pedro Aide, Tsiri Agbenyega, Marcel Tanner, Ali Mtoro, Samuel Adjei, Martina Oneko, Jahit Sacarlal, Samwel Gesase, Simon Kariuki, Marc Lievens, Pascale Vandoolaeghe, Seth Owusu-Agyei, Peter G. Kremsner, Lucas Otieno, Yolanda Guerra Mendoza
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Background We assessed the safety and immunogenicity of the RTS,S/AS01 malaria vaccine in a subset of children identified as HIV-infected during a large phase III randomized controlled trial conducted in seven sub-Saharan African countries. Methods I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5de7dca589347c24bc0a07f1f5917258
https://edoc.unibas.ch/75673/
https://edoc.unibas.ch/75673/
Publikováno v:
International Journal of Advanced Engineering Research and Science. 5:231-239
The treatment performance of community based (decentralized) wastewater treatment systems are not monitored by municipalities in Tanzania and therefore these systems pose pollution threat to receiving water bodies. The aim of this research is to asse
Autor:
John Lusingu, Ally Olotu, Amanda Leach, Marc Lievens, Johan Vekemans, Aurélie Olivier, Sarah Benns, Raimos Olomi, Salum Msham, Trudie Lang, Jayne Gould, Karin Hallez, Yolanda Guerra, Patricia Njuguna, Ken O Awuondo, Anangisye Malabeja, Omar Abdul, Samwel Gesase, Denise Dekker, Lincoln Malle, Sadiki Ismael, Neema Mturi, Chris J Drakeley, Barbara Savarese, Tonya Villafana, W Ripley Ballou, Joe Cohen, Eleanor M Riley, Martha M Lemnge, Kevin Marsh, Philip Bejon, Lorenz von Seidlein
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14090 (2010)
The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-c
Externí odkaz:
https://doaj.org/article/5d6738e53a6c48248ce1123b1eec70c5